<?xml version="1.0" encoding="UTF-8"?>
<p id="par0025">ZIKV is primarily transmitted to humans from bites of infected 
 <italic>Aedes aegypti</italic> or 
 <italic>Aedes albopictus</italic> mosquitoes [
 <xref rid="bib0030" ref-type="bibr">6</xref>,
 <xref rid="bib0035" ref-type="bibr">7</xref>], yet there have also been cases of sexual [
 <xref rid="bib0040" ref-type="bibr">8</xref>,
 <xref rid="bib0045" ref-type="bibr">9</xref>] and materno-fetal transmission [
 <xref rid="bib0050" ref-type="bibr">10</xref>]. Most ZIKV infections are asymptomatic. Among symptomatic cases ―which develop 6–11 days after infection― [
 <xref rid="bib0055" ref-type="bibr">11</xref>], mild signs such as headache, retro-orbital pain, maculopapular rash, fever, arthralgia, conjunctivitis, edema and vomiting are reported [
 <xref rid="bib0060" ref-type="bibr">12</xref>]. ZIKV gained attention for its causal link to microcephaly in the children of women infected while pregnant, as well as to Guillain-Barré syndrome (GBS) in adults [
 <xref rid="bib0065" ref-type="bibr">[13]</xref>, 
 <xref rid="bib0070" ref-type="bibr">[14]</xref>, 
 <xref rid="bib0075" ref-type="bibr">[15]</xref>]. The former is a neurodevelopmental disorder associated with mental retardation, learning disabilities, behavioral abnormalities, muscle weakness and altered muscle tone; whereas the latter is an autoimmune disease that causes flaccid paralysis [
 <xref rid="bib0080" ref-type="bibr">16</xref>].
</p>
